Novavax (Germany) Odds of Future Stock Price Finishing Over 13.61
| NVV1 Stock | EUR 8.38 0.53 5.95% |
Novavax |
Novavax Target Price Odds to finish over 13.61
The tendency of Novavax Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over € 13.61 or more in 90 days |
| 8.38 | 90 days | 13.61 | about 1.62 |
Based on a normal probability distribution, the odds of Novavax to move over € 13.61 or more in 90 days from now is about 1.62 (This Novavax probability density function shows the probability of Novavax Stock to fall within a particular range of prices over 90 days) . Probability of Novavax price to stay between its current price of € 8.38 and € 13.61 at the end of the 90-day period is about 83.67 .
Assuming the 90 days trading horizon the stock has the beta coefficient of 1.27 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Novavax will likely underperform. Additionally Novavax has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Novavax Price Density |
| Price |
Predictive Modules for Novavax
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Novavax. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Novavax Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Novavax is not an exception. The market had few large corrections towards the Novavax's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Novavax, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Novavax within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.27 | |
β | Beta against Dow Jones | 1.27 | |
σ | Overall volatility | 1.64 | |
Ir | Information ratio | -0.04 |
Novavax Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Novavax for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Novavax can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Novavax generated a negative expected return over the last 90 days | |
| Novavax has high historical volatility and very poor performance | |
| Novavax has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 1.15 B. Net Loss for the year was (1.74 B) with loss before overhead, payroll, taxes, and interest of (1.39 B). | |
| About 62.0% of the company shares are owned by institutional investors |
Novavax Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Novavax Stock often depends not only on the future outlook of the current and potential Novavax's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Novavax's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 75.8 M |
Novavax Technical Analysis
Novavax's future price can be derived by breaking down and analyzing its technical indicators over time. Novavax Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Novavax. In general, you should focus on analyzing Novavax Stock price patterns and their correlations with different microeconomic environments and drivers.
Novavax Predictive Forecast Models
Novavax's time-series forecasting models is one of many Novavax's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Novavax's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Novavax
Checking the ongoing alerts about Novavax for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Novavax help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Novavax generated a negative expected return over the last 90 days | |
| Novavax has high historical volatility and very poor performance | |
| Novavax has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 1.15 B. Net Loss for the year was (1.74 B) with loss before overhead, payroll, taxes, and interest of (1.39 B). | |
| About 62.0% of the company shares are owned by institutional investors |
Additional Information and Resources on Investing in Novavax Stock
When determining whether Novavax offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Novavax's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Novavax Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Novavax Stock:Check out Novavax Backtesting, Novavax Valuation, Novavax Correlation, Novavax Hype Analysis, Novavax Volatility, Novavax History as well as Novavax Performance. For more detail on how to invest in Novavax Stock please use our How to Invest in Novavax guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.